65535 arm_groups with arm group type Experimental
- GVHD regimen 3 (open to accrual as of 2/11/02) (Arm Group)
- GVHD regimen 2 (open to accrual from 10/17/00 through 2/11/02) (Arm Group)
- GVHD regimen 1 (closed to accrual as of 10/17/00) (Arm Group)
- Preparative regimen 3 (closed to accrual as of 10/1/03) (Arm Group)
- Preparative regimen 2 (closed to accrual as of 10/1/03) (Arm Group)
- Preparative regimen 1 (Arm Group)
- Mynx VCD (Arm Group)
- Temsirolimus, cisplatin, erlotinib (Arm Group)
- Arm 1 (Arm Group)
- Erythropoietin and cell saver (Arm Group)
- drain (Arm Group)
- cell saver (Arm Group)
- Erythropoietin (Arm Group)
- Exercise and diastolic dysfunction (Arm Group)
- 1 (Arm Group)
- Pemetrexed, Cisplatin, Bevacizumab (Arm Group)
- Ranolazine (Arm Group)
- BIBW 2992 + BIBF 1120 (Arm Group)
- Allogeneic arm (Arm Group)
- Propofol (Arm Group)
